Literature DB >> 35535921

Long-term functional outcomes and mortality after hospitalization for extracranial hemorrhage.

Anna L Parks1, Sun Y Jeon2, W John Boscardin2,3, Michael A Steinman2, Alexander K Smith2, Kenneth E Covinsky2, Margaret C Fang4, Sachin J Shah4.   

Abstract

BACKGROUND: The effects of extracranial hemorrhage (ECH), or bleeding outside the brain, are often considered transient. Yet, there are few data on the long-term and functional consequences of ECH.
OBJECTIVE: Define the association of ECH hospitalization with functional independence and survival in a nationally representative cohort of older adults.
DESIGN: Longitudinal cohort study. SETTINGS AND PARTICIPANTS: Data from the Health and Retirement Study from 1995 to 2016, a nationally representative, biennial survey of older adults. Adults aged 66 and above with Medicare linkage and at least 12 months of continuous Medicare Part A and B enrollment. INTERVENTION: Hospitalization for ECH. MAIN OUTCOMES AND MEASURES: Adjusted odds ratios and predicted likelihood of independence in all activities of daily living (ADLs), independence in all instrumental activities of daily living (IADLs) and extended nursing home stay. Adjusted hazard ratio and predicted likelihood for survival.
RESULTS: In a cohort of 6719 subjects (mean age 77, 59% women) with average follow-up time of 8.3 years (55,767 person-years), 736 (11%) were hospitalized for ECH. ECH was associated with a 15% increase in ADL disability, 15% increase in IADL disability, 8% increase in nursing home stays, and 4% increase in mortality. After ECH, subjects became disabled and died at the same annual rate as pre-ECH but never recovered to pre-ECH levels of function. In conclusion, hospitalization for ECH was associated with significant and durable declines in independence and survival. Clinical and research efforts should incorporate the long-term harms of ECH into decision-making and strategies to mitigate these effects.
© 2022 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2022        PMID: 35535921      PMCID: PMC9558016          DOI: 10.1002/jhm.12799

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.899


  39 in total

1.  Death and disability from warfarin-associated intracranial and extracranial hemorrhages.

Authors:  Margaret C Fang; Alan S Go; Yuchiao Chang; Elaine M Hylek; Lori E Henault; Nancy G Jensvold; Daniel E Singer
Journal:  Am J Med       Date:  2007-05-24       Impact factor: 4.965

2.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

3.  Efficacy and Safety of Early vs Elective Colonoscopy for Acute Lower Gastrointestinal Bleeding.

Authors:  Ryota Niikura; Naoyoshi Nagata; Atsuo Yamada; Tetsuro Honda; Kenkei Hasatani; Naoki Ishii; Yasutoshi Shiratori; Hisashi Doyama; Tsutomu Nishida; Tetsuya Sumiyoshi; Tomoki Fujita; Shu Kiyotoki; Tomoyuki Yada; Katsumi Yamamoto; Tomohiro Shinozaki; Munenori Takata; Tatsuya Mikami; Katsuhiro Mabe; Kazuo Hara; Mitsuhiro Fujishiro; Kazuhiko Koike
Journal:  Gastroenterology       Date:  2019-09-26       Impact factor: 22.682

4.  Risk factors for hospitalized gastrointestinal bleeding among older persons. Cardiovascular Health Study Investigators.

Authors:  R C Kaplan; S R Heckbert; T D Koepsell; C D Furberg; J F Polak; R E Schoen; B M Psaty
Journal:  J Am Geriatr Soc       Date:  2001-02       Impact factor: 5.562

5.  Progress in development of the index of ADL.

Authors:  S Katz; T D Downs; H R Cash; R C Grotz
Journal:  Gerontologist       Date:  1970

6.  Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.

Authors:  Mark H Eckman; Ruth E Wise; Katherine Naylor; Lora Arduser; Gregory Y H Lip; Brett Kissela; Matthew Flaherty; Dawn Kleindorfer; Faisal Khan; Daniel P Schauer; John Kues; Alexandru Costea
Journal:  Curr Med Res Opin       Date:  2015-03-13       Impact factor: 2.580

7.  US Emergency Department Visits Attributed to Medication Harms, 2017-2019.

Authors:  Daniel S Budnitz; Nadine Shehab; Maribeth C Lovegrove; Andrew I Geller; Jennifer N Lind; Daniel A Pollock
Journal:  JAMA       Date:  2021-10-05       Impact factor: 56.272

8.  Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.

Authors:  David J Graham; Marsha E Reichman; Michael Wernecke; Ya-Hui Hsueh; Rima Izem; Mary Ross Southworth; Yuqin Wei; Jiemin Liao; Margie R Goulding; Katrina Mott; Yoganand Chillarige; Thomas E MaCurdy; Chris Worrall; Jeffrey A Kelman
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

9.  Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.

Authors:  Jordan K Schaefer; Josh Errickson; Yun Li; Xiaowen Kong; Tina Alexandris-Souphis; Mona A Ali; Deborah Decamillo; Brian Haymart; Scott Kaatz; Eva Kline-Rogers; Jay H Kozlowski; Gregory D Krol; Sahana R Shankar; Suman L Sood; James B Froehlich; Geoffrey D Barnes
Journal:  JAMA Intern Med       Date:  2021-06-01       Impact factor: 21.873

10.  Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant Use in a National Cohort of Older Americans.

Authors:  Sachin J Shah; Margaret C Fang; Sun Y Jeon; Steven E Gregorich; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2020-09-28       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.